The goal of the Massachusetts Consortium on Pathogen Readiness (MassCPR) is to develop and invest in both the research process and supporting infrastructure to address the current global COVID-19 pandemic, and better position the Consortium for potential future outbreaks.

The initial efforts of the MassCPR are aimed at elucidating the basic biology of the SARS-CoV-2 virus and the pathogenesis of the resulting disease, developing new diagnostic tools, vaccines, and antiviral therapies, creating and using animal and other model systems, understanding disease epidemiology, and leveraging clinical expertise to improve medical management.